US Stock Profits exceeded expectations in the second quarter, with a rise of 11.8% compared to the previous year, surpassing the initial estimate of 4.9%. The convergence of prices and fair values has been primarily driven by better-than-expected results rather than price changes, offering average long-term returns. Tech stocks remain expensive, while traditional industry stocks are undervalued, presenting opportunities for investors willing to look beyond benchmark indexes. Most US active funds continue to underperform passive peers, highlighting the need for patience and optimism in investing.

Global Trade tariffs are back in focus as the US-China agreement expiration looms, potentially impacting asset prices. Healthcare stocks have suffered a 4% decline year-to-date, priced at an 11% discount to fair value. US tariffs on gold imports from Switzerland led to a spike in gold futures, emphasizing the challenges of managing global supply chains amid trade friction.

Pension investors can now access alternative assets and cryptocurrencies through 401(k) plans, with the aim of increasing investment flexibility. However, these new strategies come with challenges such as higher costs and reduced flexibility, requiring careful consideration before implementation. Emerging markets, including Developed and Emerging Markets ex-US, continue to offer attractive opportunities over US markets, reinforcing the benefits of international diversification. Weak economic data and pressure from President Trump suggest a rate cut at the September Federal Reserve meeting, with investors expecting further cuts by year-end. The release of the Consumer Price Index data this week will be crucial in shaping future rate decisions, with any significant deviation likely to impact investor sentiment.

Read more at Morningstar: Patient Investors Rewarded in Earnings Season